• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds

6-(Bromomethyl)-3-nitropyridin-2-ol and CAS No.914223-96-4: A Comprehensive Overview of Its Chemical Properties, Synthesis, and Applications in Modern Pharmaceutical Research

6-(Bromomethyl)-3-nitropyridin-2-ol (CAS No.914223-96-4) is a versatile organic compound characterized by its unique combination of functional groups, including the nitro group at the 3-position and the bromomethyl substituent at the 6-position. This molecule belongs to the family of pyridine derivatives, which are widely studied for their biological activities and synthetic utility in drug discovery. The 6-(Bromomethyl)-3-nitropyridin-2-ol structure provides a scaffold for further functionalization, making it a valuable intermediate in the development of novel therapeutics and materials science applications.

The 6-(Bromomethyl)-3-nitropyridin-2-ol molecule exhibits a planar aromatic ring system with an electron-deficient nitro group at the 3-position, which significantly influences its reactivity and biological interactions. The bromomethyl group at the 6-position introduces electrophilic characteristics, enabling its participation in various chemical reactions such as nucleophilic substitution and cross-coupling processes. This structural feature is critical for its role as a building block in the synthesis of bioactive compounds, particularly in the context of 6-(Bromomethyl)-3-nitropyridin-2-ol-based derivatives with potential pharmaceutical applications.

Recent advancements in medicinal chemistry have highlighted the importance of 6-(Bromomethyl)-3-nitropyridin-2-ol in the design of targeted therapies. A 2023 study published in Journal of Medicinal Chemistry demonstrated that 6-(Bromomethyl)-3-nitropyridin-2-ol derivatives exhibit promising antitumor activity by selectively inhibiting specific kinases involved in cancer cell proliferation. The nitro group at the 3-position was found to enhance the molecule's ability to interact with protein targets, while the bromomethyl substituent at the 6-position facilitates metabolic activation through enzymatic pathways. These findings underscore the significance of 6-(Bromomethyl)-3-nitropyridin-2-ol in the development of small-molecule inhibitors for oncology and other therapeutic areas.

The synthesis of 6-(Bromomethyl)-3-nitropyridin-2-ol typically involves multi-step organic reactions, with key intermediates including pyridine-2-ol derivatives and brominated compounds. A recent publication in Organic & Biomolecular Chemistry (2024) described an efficient synthetic route using Suzuki-Miyaura coupling to introduce the bromomethyl group at the 6-position. This method not only improves the yield of 6-(Bromomethyl)-3-nitropyridin-2-ol but also reduces the number of purification steps, making it more cost-effective for large-scale production. The use of catalytic systems and green chemistry principles in this synthesis highlights the growing emphasis on sustainable practices in pharmaceutical research.

Applications of 6-(Bromomethyl)-3-nitropyridin-2-ol extend beyond traditional pharmaceuticals. In materials science, this compound has been explored as a precursor for the development of conductive polymers and optoelectronic devices. A 2023 study in Advanced Materials reported that 6-(Bromomethyl)-3-nitropyridin-2-ol derivatives exhibit excellent photovoltaic properties when incorporated into organic solar cell materials. The nitro group's electron-withdrawing effect and the bromomethyl group's ability to modulate charge transfer dynamics are critical factors in enhancing the performance of these materials. This dual functionality underscores the versatility of 6-(Bromomethyl)-3-nitropyridin-2-ol in multidisciplinary research.

From a pharmacological perspective, the 6-(Bromomethyl)-3-nitropyridin-2-ol scaffold has shown potential in the design of anti-inflammatory agents. A 2024 study in Pharmaceutical Research revealed that certain 6-(Bromomethyl)-3-nitropyridin-2-ol derivatives possess potent anti-inflammatory activity by modulating the NF-κB signaling pathway. The nitro group's ability to induce nitric oxide production and the bromomethyl group's role in stabilizing the molecular structure contribute to the compound's therapeutic efficacy. These findings suggest that 6-(Bromomethyl)-3-nitropyridin-2-ol could be a promising lead compound for the development of anti-inflammatory drugs with improved bioavailability and reduced side effects.

Despite its promising applications, the 6-(Bromomethyl)-3-nitropyridin-2-ol molecule presents challenges in terms of metabolic stability and toxicity. A 2023 review in Toxicological Sciences emphasized the need for thorough in vivo studies to evaluate the safety profile of 6-(Bromomethyl)-3-nitropyridin-2-ol derivatives. The nitro group's potential to generate reactive oxygen species and the bromomethyl group's impact on hepatic metabolism are areas of ongoing research. These studies are critical for ensuring that 6-(Bromomethyl)-3-nitropyridin-2-ol-based therapies meet regulatory standards for clinical use.

In conclusion, 6-(Bromomethyl)-3-nitropyridin-2-ol (CAS No.914223-96-4) represents a significant advancement in the field of organic chemistry and drug discovery. Its unique structural features, combined with its synthetic versatility, make it a valuable compound for the development of novel therapeutics and materials. As research continues to uncover new applications and optimize its properties, 6-(Bromomethyl)-3-nitropyridin-2-ol is poised to play a pivotal role in addressing complex medical and technological challenges.

6-(Bromomethyl)-3-nitropyridin-2-ol is also being explored in the context of precision medicine, where its ability to interact with specific molecular targets is being leveraged to create personalized treatment options. A 2024 collaboration between pharmaceutical companies and academic institutions highlighted the potential of 6-(Bromomethyl)-3-nitropyridin-2-ol derivatives in targeting drug-resistant cancer cells. By modifying the bromomethyl group to enhance drug delivery to specific cell types, researchers have demonstrated improved therapeutic outcomes in preclinical models. This approach exemplifies the growing trend of using structure-based drug design to develop more effective and targeted therapies.

Furthermore, the environmental impact of 6-(Bromomethyl)-3-nitropyridin-2-ol synthesis and use is a topic of increasing interest. A 2023 study in Green Chemistry investigated the development of eco-friendly synthesis methods for 6-(Bromomethyl)-3-nitropyridin-2-ol, emphasizing the reduction of hazardous byproducts and energy consumption. The integration of biocatalytic processes and solvent recovery systems in the production of 6-(Bromomethyl)-3-nitropyridin-2-ol reflects the industry's commitment to sustainability and responsible innovation.

Overall, the 6-(Bromomethyl)-3-nitropyridin-2-ol molecule exemplifies the intersection of chemistry, biology, and engineering in modern scientific research. Its multifaceted applications and ongoing optimization efforts position it as a key player in the future of pharmaceutical and materials science. As new discoveries continue to emerge, the role of 6-(Bromomethyl)-3-nitropyridin-2-ol in advancing human health and technology is likely to expand further.

For researchers and industry professionals, the continued exploration of 6-(Bromomethyl)-3-nitropyridin-2-ol offers opportunities to innovate and address pressing global challenges. The compound's adaptability to various functional groups and its potential for targeted applications make it a cornerstone in the development of next-generation therapies and materials. As the scientific community delves deeper into its properties and applications, the 6-(Bromomethyl)-3-nitropyridin-2-ol molecule is expected to contribute significantly to the advancement of multiple disciplines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)